HealthEquity Inc

NASDAQ HQY

Data sourced from iex and EODHD
Download Data

HealthEquity Inc Income Statement 2013 - 2024

This table shows the Income Statement for HealthEquity Inc going from 2013 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 2016-07-31 2016-04-30 2016-01-31 2015-10-31 2015-07-31 2015-04-30 2015-01-31 2014-10-31 2014-07-31 2014-04-30 2014-01-31 2013-10-31 2013-07-31 2013-04-30 2013-01-31
Revenue
M 262 249 244 244 234 216 206 206 203 180 189 184 188 179 176 190 201 157 87 87 76 70 71 70 60 57 57 55 47 43 44 44 36 31 30 30 25 22 21 20 17 15 15 15 12
Cost of Revenue
M 122 91 93 97 100 89 88 95 98 77 77 81 87 75 74 82 88 61 28 29 31 25 24 26 29 23 21 22 23 17 16 16 17 13 12 12 12 10 9 9 9 7 7 7 6
Gross Profit
M 140 158 151 148 134 127 118 111 105 103 112 103 101 105 102 108 114 96 58 58 44 46 47 44 32 34 36 34 24 26 29 28 18 18 19 18 13 12 12 11 8 8 8 8 26
Operating Expenses
M 99 128 126 125 115 114 113 109 133 104 113 99 101 93 93 93 99 86 34 30 28 27 25 24 23 20 19 18 18 17 16 14 14 11 11 10 10 8 7 6 7 5 5 5 25
Selling, General, and Administrative Expenses (SG&A)
M 25 26 27 25 21 25 26 24 21 20 23 21 23 22 20 19 23 19 9 9 8 9 8 8 7 6 6 6 5 5 6 5 4 3 4 3 3 2 2 1 1 1 1 1 5
Research and Development (R&D) Expenses
M 55 56 55 53 53 49 47 45 46 38 38 35 32 31 31 31 32 24 12 11 10 9 8 8 7 7 7 6 7 6 5 5 5 4 4 4 3 3 2 2 2 2 2 2 4
Other Operating Expenses
M 18 46 44 47 41 40 40 41 66 46 52 43 46 40 42 43 44 43 13 10 9 9 9 8 9 7 6 6 7 5 5 5 6 3 3 3 4 3 3 3 4 2 2 2 16
Costs and Expenses
M -23 34 32 25 16 26 24 15 8 14 19 9 1 10 8 -2 0 7 3 1 -3 2 1 -2 -6 -3 -2 -4 -5 -1 0 -2 -3 -2 -1 -2 -2 -2 -2 -3 -2 -2 -2 -2 -6
Operating Income
M 41 31 25 23 19 12 5 2 -27 0 -1 4 0 12 9 15 15 10 25 28 17 19 22 21 8 14 16 16 6 9 13 13 4 6 7 8 2 4 5 5 2 3 4 3 1
Interest Expense
M 14 14 13 15 14 12 11 10 11 12 7 7 7 7 9 12 14 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M -11 1 -2 -13 -19 -19 -19 -20 -32 -10 -17 -12 -8 -9 -11 -14 -12 -49 -4 24 0 -2 0 0 -2 0 0 0 0 0 0 -1 0 0 -1 0 0 0 0 -1 -6 0 0 0 0
EBT
M 30 21 14 10 0 -6 -14 -18 -44 -9 -8 -6 -1 4 -1 2 -1 -31 24 51 16 17 21 21 7 13 16 16 6 9 13 13 4 6 7 8 2 4 5 5 -4 3 4 3 7
Income Tax Provision
M 3 6 4 6 0 -5 -3 -4 -11 -4 -4 -3 -7 2 -1 0 0 -10 4 9 3 2 -1 -2 1 3 0 2 2 3 4 5 1 2 3 3 1 1 2 2 0 1 1 1 0
Income after Tax
M 26 15 11 4 0 -2 -11 -14 -33 -5 -4 -3 5 2 0 2 0 -21 19 42 13 16 23 23 6 10 17 14 4 6 8 8 3 4 4 5 1 3 3 3 -5 2 2 2 7
Non-Controlling Interest
M - - 0 0 0 0 0 0 0 0 -50 0 0 0 0 0 -28 0 9 19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 1 -3 1 -2 -2 -2 -11
Net Income
M - - 11 4 0 -2 -11 -14 -33 -5 47 -3 5 2 0 2 0 -21 19 42 13 16 23 23 6 10 17 14 4 6 8 8 3 4 4 5 1 3 2 3 -1 2 2 2 11
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 87,435,000.00 87,122,000.00 86,341,000.00 86,102,000.00 84,718,000.00 84,572,000.00 84,443,000.00 84,022,000.00 83,708,000.00 83,551,000.00 83,481,000.00 81,747,000.00 78,559,000.00 77,845,000.00 72,343,000.00 72,292,000.00 70,880,000.00 70,524,000.00 65,583,000.00 63,901,000.00 63,724,000.00 63,923,000.00 63,397,000.00 62,693,000.00 62,291,000.00 61,868,000.00 61,765,000.00 61,400,000.00 60,645,000.00 60,073,000.00 59,651,000.00 59,399,000.00 59,420,000.00 59,263,000.00 58,932,000.00 57,770,000.00 57,535,000.00 57,553,000.00 41,680,000.00 49,596,105.00 8,135,000.00 41,680,000.00 41,680,000.00 41,680,000.00 -
EBITDA
M 79 61 68 68 60 53 46 41 32 36 51 41 49 49 47 55 52 16 35 32 21 24 26 25 13 18 20 19 10 12 16 16 5 7 8 8 2 5 5 7 2 5 5 4 -
Depreciation and Amortization
M 38 23 38 44 40 41 41 39 39 20 33 32 30 29 29 28 27 19 5 5 5 5 4 5 5 4 4 3 4 3 3 3 1 0 0 0 0 0 0 1 1 1 1 1 -
EBIT
M 41 37 30 23 19 12 5 2 -7 16 18 9 18 19 19 27 25 -3 30 28 17 19 22 21 8 14 16 16 6 9 13 13 4 6 7 8 2 4 5 5 1 4 4 3 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax Rate (Effective)
% 11.28 30.42 25.61 59.11 2,712.50 73.45 23.20 24.44 25.01 44.79 50.96 56.89 499.93 56.67 78.58 10.67 68.70 31.74 18.41 18.44 19.81 10.01 -4.79 -9.92 12.23 20.39 -2.97 11.42 32.56 31.62 35.18 35.97 27.19 36.39 36.44 36.82 28.67 26.51 39.83 41.69 -9.70 39.29 37.81 38.45 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Gross Profit Margin
% 53.40 63.56 61.97 60.48 57.41 58.71 57.15 54.05 51.80 57.41 59.21 55.98 53.63 58.30 57.82 56.88 56.50 61.12 67.46 66.34 58.65 64.99 65.54 63.45 52.36 59.39 62.94 60.88 51.76 59.71 64.62 62.89 51.36 57.85 60.95 59.99 50.31 55.95 56.34 56.64 49.08 54.94 55.69 52.37 209.19
Operating Income Margin
% 15.69 12.40 10.16 9.48 8.31 5.78 2.57 0.83 -13.40 -0.20 -0.46 2.31 0.08 6.41 5.13 7.93 7.23 6.31 28.70 31.79 21.88 26.93 30.34 29.38 13.96 23.88 29.00 28.74 13.20 20.85 28.83 30.10 12.15 20.63 24.59 26.74 8.12 19.64 24.27 27.13 9.26 22.27 24.12 20.01 6.95
Net Income Margin
% - - 4.34 1.67 -0.09 -0.76 -5.17 -6.63 -16.14 -2.80 24.66 -1.42 2.85 1.00 -0.08 0.96 -0.09 -13.58 22.36 48.04 17.31 22.25 31.68 32.30 9.77 18.46 29.79 25.31 8.68 13.86 18.63 18.34 8.72 13.38 14.50 16.67 5.51 13.81 7.49 13.43 -4.34 12.97 14.83 11.97 90.39
EBITDA Ratio
% 30.14 24.28 27.87 27.62 25.61 24.52 22.34 20.03 15.83 19.81 26.73 22.37 25.92 27.13 26.79 28.73 25.86 10.00 40.84 37.28 28.07 33.43 36.53 35.85 21.91 30.94 35.42 35.02 20.99 28.74 36.02 36.80 14.88 21.97 25.93 28.11 9.38 21.51 26.04 32.86 14.46 30.54 30.65 26.21 -
EBIT Ratio
% 15.69 14.96 12.13 9.48 8.31 5.78 2.57 0.83 -3.26 8.89 9.26 5.12 9.76 10.75 10.55 14.25 12.66 -2.13 35.13 31.79 21.88 26.93 30.34 29.38 13.96 23.88 29.00 28.74 13.20 20.85 28.83 30.10 12.15 20.63 24.59 26.74 7.73 19.64 24.09 26.67 7.87 22.99 23.92 19.51 0.00
EBT Ratio
% 11.33 8.46 5.84 4.10 0.00 -2.86 -6.73 -8.78 -21.53 -5.07 -4.12 -3.29 -0.71 2.30 -0.39 1.08 -0.30 -19.89 27.40 58.91 21.59 24.73 30.24 29.38 11.13 23.19 28.93 28.58 12.87 20.26 28.75 28.65 11.97 21.03 22.81 26.39 7.73 18.98 24.09 23.04 -25.06 21.37 23.85 19.44 52.62

StockViz Staff

September 8, 2024

Any question? Send us an email